By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call
Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call
Health

Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call

GlobeNews Wire
Last updated: 25/04/2026 1:38 PM
GlobeNews Wire
Published: 25/04/2026
Share
SHARE

MINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) — Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the quarter ended March 31, 2026 after market close on Wednesday, May 13, 2026.

The Company will host a conference call to discuss these results the next day on Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

A live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call.

Conference Call Details

  • Date: May 14, 2026
  • Time: 8:30 a.m. Eastern Time (7:30 a.m. Central Time)
  • Webcast: Link to Webcast Registration
  • Conference Call: Link to Conference Call Registration

About Park Dental Partners, Inc.

Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. As of year-end 2025, the Company had 214 affiliated doctors across 86 practice locations in three states. The Company’s clinical support team consisted of approximately 990 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today.

Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com.



The Phoenix ED Device: Can This Modern Tech Really Bring Back the Spark?
Bitget Rallies Over 1,000 Next-Gen Talent at HKUST to Shape the Future of Web3
OSS Announces the Sale of Bressner Technology GmbH to Hiper Euro GMBH
Firstsource named a ‘Star Performer’ and a ‘Major Contender’ in Everest Group’s Financial Crime and Compliance (FCC) Operations Services PEAK Matrix Assessment 2025
Andor Health’s Agentic AI Platform, ThinkAndor, Receives Frost & Sullivan’s 2025 North American Transformational Innovation Leadership Recognition for Excellence in Acute Care Virtual Health
TAGGED:2026andannouncescallconferencedatesdentalearningsfirstforNasdaq:PARKnewsparkpartnersquarterreleaseUS7004021009
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
BioNTech and DualityBios Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
Health

BioNTech and DualityBios Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

GlobeNews Wire
GlobeNews Wire
12/04/2026
Companies Struggle to Meet Rising Demand for Personalized Benefits, Aon Survey Finds
BrowserStack Launches Accessibility Design Toolkit to Shift Accessibility Left
Kia Marks 80Year Journey with Ceremony and Exhibition Celebrating its Heritage and Vision
Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?